As the New Year comes, Angel Investment Company, which is committed to the biological field O2H Ventures, has announced that he has won three awards, including the "Special Contribution Award of the Biological Field" of the SME Ministry, the "Annual Growth Award" and "Oxford Life Sciences of the British Angel Investment Association" and the British Angel Investment Associationaward".
O2H Ventures was founded in 2018 by the two brothers and entrepreneurs and investment experts in the fields of digital biotechnology.The founder has more than 20 years of experience in the industry, so it quickly rose in the field of biological sciences in London.
The company's co -founder and CEO Sonier Sha is a successful continuous entrepreneur and a very active angel investor. He is committed to investing in the field of life sciences and biopharmaceuticals.indivual.He has a master's degree in biopharmaceuticals and business management from Cambridge University. After graduation, he started his career at a biological information technology company.After entering the consecutive entrepreneurial state, after his second company was acquired, he fell in love with angel investment.He firmly believes that biotechnology has huge opportunities, and he can use his professional knowledge, skills, social networks and resources to help start -up companies achieve their goals.
Company co -founder and CEO Sonier Sha
Suniel Sa is a member of the board of directors of Cambridge Angel Investment Organization. Here, he has learned a lot of angel investment knowledge and skills with his companions.Greatly increase the success rate of investment."Cambridge Angel Investment Organization Big Coffee is like a cloud, there are at least 60 founders of high -tech companies here. If I invest in high -tech projects, I will follow them; of course, if they are investing in biotechnology projects, they will hear my suggestionsOpinion.
Sunier believes that the British biotechnology industry is facing huge opportunities: "Entrepreneurs in the field of biotechnology in the United States have a good entrepreneurial environment, so they have received a lot of funds support; British biological science is very developed, but in terms of business conversion, in terms of business conversion,Relatively lack of this is our faith: British technology is facing the global market. The patent here can benefit the people of the European Union, the United States, Japan or other countries. "
He particularly emphasized that because many international pharmaceutical companies are headquartered in Europe, there are rich investment opportunities here: "At our doorstep, we have incredible good investment opportunities! This is the birthplace of many cutting -edge scientific achievements,We can discover them in the early days; we also know the goals where the medical giants want to acquire.Cooperate with them ""Kanpur Investment
The company has obtained the honor of life and health many times
Sunier said that the field of biotechnology, like other science and technology, is undergoing huge revolution and unprecedented growth."In the next 10 years, humans face a new technological revolution, and this revolution has also occurred in the field of biotechnology. Now biotechnology companies are looking for new opportunities. They look forward to cooperating with early biotechnology companies.The best time to start a business in biotechnology.Pune Investment
Due to the 20 years of cultivation in the field of biotechnology, Sonier and his team have accumulated rich experience, resources, and social network relationships in the industry, which allows them to bring more added value to startups.Investment, when they get the next round of investment, and the entrepreneurial enterprises are acquired or listed, they have unique advantages.These advantages have been verified in the growth of several companies that have invested.This is also the main reason why the British Angel Investment Association awarded his annual character award.
"Thank you very much for the recognition of us by the British Angel Investment Association, which is also the honor of our investment companies." Senier said, "After winning this award, our popularity in the industry has greatly improved, which will bring us moreMore excellent projects and opportunities. "
The company won the 2023 Growth Award
Sunier is a technical optimism. He believes that the uncertainty and political turmoil facing the world at present will not have much negative impact on the British biotechnology industry."British biotechnology is the lead in Europe. It is second only to the United States worldwide. The potential of British biotechnology is huge. In terms of attracting employment and driving economic growth, it will play a greater role;Formulating policies will pay attention and support the biotechnology industry.
Regarding the return of investment, Sonier has his own point of view. He believes that he is a value investor, that is, pay attention to and pay attention to the social value of the enterprise without paying attention to the way of exit."Some investors consider exiting and returning after investing, and considering how to sell companies all day. They spend too much effort on these issues. Discussing exit on the company's board of directors will have a negative impact on entrepreneurs.I have never rushed to withdraw, and I do n’t think about how to sell the enterprise: I only care about it, is the entrepreneur focus on solving the problem.
The judges agree that O2H Ventures has won the "annual growth award" by the British Angel Investment Association, which can encourage more angel investors to strengthen support for biotechnology and promote the diversification of the angel investment industry.Sunier is an entrepreneur from India. He has a wide range of connections and cooperation with India's biotechnology industry and investment industry.
Article Address： https://marygk9999.com/FI/63.html
Article Source：Admin88
Notice：Please indicate the source of the article in the form of a link。
